About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Candesartan Effect in Second Stage Arterial Hypertension

Candesartan Effect in Second Stage Arterial Hypertension

NCT00621153·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Stage II essential hypertension (SBP≥ 160 or DBP≥100 mmHg), untreated, or treated with a maximum of 2 class of antihypertensive drugs

You may not be if

Current serum-creatinine \>3 mg/dL, Current serum-potassium \>5.5 mmol/L, 16.
Pregnant or lactating women or women of childbearing potential who were not protected from pregnancy

The record

StatusCompleted

PhasePhase 4

Taking part214

StartedFeb 2008

UpdatedMar 23, 2010

Conditions

Stage II Hypertension

Where1

Research Site
Seoul, South Korea